Clinical Trials Directory

Trials / Completed

CompletedNCT01887860

Patch Test Skin Irritation/Sensitization of Cetaphil Daily Facial Moisturizer SPF 50

Subject Repeat Insult Patch Test Skin Irritation/Sensitization Evaluation (Occlusive Patch)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Galderma R&D · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Determine if Cetaphil Daily Facial Moisturizer SPF 50 proves to be a contact sensitizer or irritant in certain individuals.

Conditions

Interventions

TypeNameDescription
OTHERCetaphil Daily Facial Moisturizer SPF 50Other: Cetaphil Daily Advance Ultra Hydrating Lotion 0.2ml or 0.2g of Cetaphil on occlusive, hypoallergenic patch applied to skin for 24 hrs 9 times on Monday, Wednesday, and Friday for 3 weeks

Timeline

Start date
2012-12-01
Primary completion
2013-01-01
First posted
2013-06-27
Last updated
2022-07-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01887860. Inclusion in this directory is not an endorsement.